These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19911468)

  • 1. [The use of reminyl (galantamine) in the treatment of probable vascular dementia].
    Mokhova OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):77-9. PubMed ID: 19911468
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of galantamine in Alzheimer's disease associated with vascular dementia (according to the study of T. Erkinjuntti group)].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):65-7. PubMed ID: 19938276
    [No Abstract]   [Full Text] [Related]  

  • 3. [EEG and clinical psychophysiological study of functional changes in the chronic ischemic brain with increased acetylcholinergic activity].
    Sorokina ND; Selitskiĭ GV; Kositsyn NS
    Fiziol Cheloveka; 2007; 33(3):35-9. PubMed ID: 17619614
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-cognitive benefits of galantamine (Reminyl) treatment in vascular dementia.
    Kurz A
    Acta Neurol Scand Suppl; 2002; 178():19-24. PubMed ID: 12492788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of reminyl (galantamine) in the treatment of dementia].
    Voronkova KV; Pylaeva OA; Mazal'skaia OV; Lemeshko ID; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):26-30. PubMed ID: 16608108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular dementia: galantamine (Reminyl) as an emerging therapeutic option.
    Small GW
    Acta Neurol Scand Suppl; 2002; 178():4-5. PubMed ID: 12492784
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive decline and treatment options for patients with vascular dementia.
    Erkinjuntti T
    Acta Neurol Scand Suppl; 2002; 178():15-8. PubMed ID: 12492787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reminyl efficacy in dementia with Levi bodies].
    Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):15-21. PubMed ID: 16281374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Traditional dementia concepts in transition--must we change our views?].
    Nervenarzt; 2005 Sep; 76(9):2p following 1164. PubMed ID: 16320378
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phenotropil in the treatment of vascular encephalopathy].
    Gustov AA; Smirnov AA; Korshunova IuA; Andrianova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):52-3. PubMed ID: 16608112
    [No Abstract]   [Full Text] [Related]  

  • 11. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
    Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
    Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of galantamine to treat vascular dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Bava A
    Lancet; 2002 Nov; 360(9344):1512-3; author reply 1513. PubMed ID: 12433549
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment options: the latest evidence with galantamine (Reminyl).
    Erkinjuntti T
    J Neurol Sci; 2002 Nov; 203-204():125-30. PubMed ID: 12417370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Emelin AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):25-33. PubMed ID: 18427456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl).
    Maelicke A
    Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of galantamine to treat vascular dementia.
    van Gool WA
    Lancet; 2002 Nov; 360(9344):1512; author reply 1513. PubMed ID: 12433548
    [No Abstract]   [Full Text] [Related]  

  • 18. Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease after treatment with galantamine.
    Erkinjuntti T
    Eur J Neurol; 2002 Sep; 9(5):545. PubMed ID: 12220392
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen.
    Thavichachart N; Phanthumchinda K; Chankrachang S; Praditsuwan R; Nidhinandana S; Senanarong V; Poungvarin N
    Int J Clin Pract; 2006 May; 60(5):533-40. PubMed ID: 16700849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial.
    Erkinjuntti T; Kurz A; Gauthier S; Bullock R; Lilienfeld S; Damaraju CV
    Lancet; 2002 Apr; 359(9314):1283-90. PubMed ID: 11965273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.